Jinnan Yue

Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3

Jinnan Yue, Dacheng Lv, Caiyun Wang et al. · Oncogene · 2018 · 111 citations · Full text

Egfr Tki Resistance, Gefitinib Resistance, Cancer Biology +23

SIRT3-mediated deacetylation of NLRC4 promotes inflammasome activation

Chenyang Guan, Xian Huang, Jinnan Yue et al. · Theranostics · 2021 · 67 citations · Full text

Acquired Resistance to EGFR TKIs Mediated by TGFβ1/Integrin β3 Signaling in EGFR-Mutant Lung Cancer

Caiyun Wang, Tao Wang, Dacheng Lv et al. · Molecular Cancer Therapeutics · 2019 · 65 citations

Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC

Ling Li, Xiajing Gu, Jinnan Yue et al. · Oncotarget · 2017 · 34 citations · Full text

Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC)

Qingnan Zhao, Jinnan Yue, Chun Zhang et al. · Oncotarget · 2015 · 31 citations · Full text